Interstitial Lung Diseases Interdisciplinary Network
a hub for research, education & best practice
Advancing Interstitial
Lung Disease Healthcare:
A network serving as a valuable resource for healthcare professionals working in the field of ILD, promoting research, education, and best practice in the diagnosis and management of these lung disorders.
Support
The ILD-IN provides a supportive network for all members, encourages information sharing and promotes best practice and research collaboration.
Education
The ILD-IN provides resources and materials and encourages members to develop knowledge and expertise in ILD care.
Influence
Through peer support and education, the ILD-IN aims to raise the standard and provision of ILD care.
Join ILD-IN Today
Our purpose is to provide a supportive network for health professionals of all disciplines working in interstitial lung diseases. We provide support, promote ILD specialty practice through education and professional development and influence the policy of ILD care.
- Member Support
- Member Education
- Learning Resources
- Discounted Conferences Rates
Join ILD-IN today and become a vital part of the ILD healthcare revolution!
Annual Membership:
£25 per year
Find The Resources You're Looking For
members only
members only
members only
About Us
The Interstitial Lung Disease Interdisciplinary Network (ILD-IN) is a supportive and collaborative network for health professionals of all disciplines caring for people with interstitial lung disease (ILD).
Latest News
Stay connected, stay informed. Explore our news articles and be at the forefront of ILD healthcare. Together, we strive for a brighter and healthier future for all those affected by ILD.
Regional Networks
The ILD-IN is keen to support the development of regional networks supporting healthcare professionals specialising in ILD locally.
New and established regional groups and their contacts are listed along with details of the next planned meeting. We would be pleased to list your network.
Latest Updates
Take a look at our social wall to stay up-to-date on the latest events and news in the industry.
Overwhelmed to receive the rising star award @ild_inn conference. Feeling extremely lucky to be part of such a great team @WWLNHS ILD is my passion and to help a patients journey in just a small way is enough for me 😊 @Kim_Whiteside @r_mccarren @k_mantron
And with that, ILD-IN conference 2025 is over! Thank you to all our speakers, delegates and exhibitors. We hope everyone has had a fantastic couple of days. Attendees will receive a feedback form and save the date for next year, we hope to see you back in Birmingham in 2026!
Closing out conference are Josh Burrough and Terri Collier, presenting on the workings of the HOSAR, oxygen therapy and current challenges. Dr Conal Hayton delivers our final talk with a focus on ILA - how should we be following up on this patient cohort?
Reply on Twitter 1975183980270965211
Retweet on Twitter 1975183980270965211
2
Like on Twitter 1975183980270965211
3
Twitter
1975183980270965211
Thanks for wrapping up conference with such an interesting talk @ConalHayton 🎙️ Our members will be keeping their eyes peeled for further developments and guidance in ILA.
Our next session is underway. Firstly, we have Rasleen Kahai delivering a talk on Dietetic Interventions in ILD Management. An overlooked component of the ILD MDT?
Our second talk this morning is being delivered by Dr Sabrina Bajwah. Dr Bajwah is discussing the role of palliative care in ILD, with an interesting focus on how culture and background can impact palliative care from both a clinician and patient perspective.
Day 2 is underway at ILD-IN conference 2025! We are in conversation with Andy Bright from APF and Dr Amit Adalaka regarding lung transplant from life pre transplant through to post transplant.
This year we've introduced the round table! Our delegates have been locked in discussion regarding key ILD themes. Building the ideal MDT, Preparing for progress and Designing the ILD Service of the the future are the hot topics up for deliberation.
The winner of our abstract session will be announced alongside our other awards during tonight's gala dinner!
The team from WWL NHS trust have sparked great debate with their abstract on high flow nasal oxygen! We're finishing with Emily Scott who is presenting an abstract looking at liver impairment in ILD patients using Nintedanib. Well done to all our presenters in this session!
